Tag Archives: Sovaldi

The Porcine Prerogative: A Perilous Precedent

While not falling within the CNS arena per se, the consequences of Gilead Pharma‘s decision to platinum-price Sovaldi for Hepatitis C, to the tune of $84,000 per three month treatment cycle in the US, eventually will permeate health care in … Continue reading

Posted in Big Pharma | Tagged , , , | 24 Comments